Implications for the weight loss drug market: Government restrictions on GLP-1 access in the UK provide an opportunity for private healthcare companies to meet consumer demand
Additionally, we scrutinized the effect of radiation on body weight, observing notable changes across all groups at week 5, with variations also evident at weeks 3 and 4 [Figures 1]
Reassurance and watchful waiting are often appropriate, as telogen effluvium is typically self-limiting
Is It Necessary? Current Opinion in Clinical Nutrition and Metabolic Care, vol
This led to off-label use for weight loss and prompted drug companies to seek FDA approval for this class of medicines to manage obesity
Diabetes-related cardiovascular outcomes were not explored in detail, other than captured as a general organ system (cardiovascular disorders) in terms of safety outcomes